Commercialization of seizure prediction technology. Promises and pitfalls of biosignal analysis: seizure prediction and management (a case study);

This presentation will focus on the process of commercializing technology designed to predict/detect seizures. The author will present general design criteria for an implantable device used chronically by an individual with epilepsy to manage their seizures. He will also contrast the requirements of a commercial product with the sophisticated approaches of algorithm developers. Where an implantable product requires low power consumption, small size, and ease of use, the tendency of algorithm developers is to make use of increasingly sophisticated mathematical techniques and increasingly affordable, high speed, powerful desktop computers. The process of developing implantable medical devices requires continuous risk versus benefit assessments. A discussion of various design approaches will emphasize the trade offs which could be employed to facilitate development of a new therapeutic device with minimized risks to the patients and accommodate important advances in algorithm development.